Showing results (221-230 of 6,497) with videos related to

Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|April 3, 2025
PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysisJosé Luis Huerta, An Ta, Elizabeth Vinand, et al.
Human Vaccines & Immunotherapeutics|April 28, 2025
The microbiological characteristics and diagnosis of Streptococcus pneumoniae infection in the conjugate vaccine eraChih-Ho Chen, Chyi-Liang Chen, Lin-Hui Su, et al.
Human Vaccines & Immunotherapeutics|April 24, 2025
Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shiftsHuijing Dong, Xinmeng Wang, Yumin Zheng, et al.
Human Vaccines & Immunotherapeutics|April 23, 2025
Human papillomavirus (HPV) related oropharyngeal cancers in Canada: A multicenter retrospective cohort studyVoica Racovitan, Elizabeth Goodman, Winson Y Cheung, et al.
Human Vaccines & Immunotherapeutics|April 21, 2025
Off-label use of recombinant adjuvanted Herpes Zoster vaccine in a 10-year-old high-risk patient affected by epidermolysis bullosa: A case reportClaudia Palmieri, Chiara Noviello, Lorenza Moscara, et al.
Human Vaccines & Immunotherapeutics|March 29, 2025
COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community settingTianshuo Zhao, Xianming Cai, Sihui Zhang, et al.
Human Vaccines & Immunotherapeutics|April 1, 2025
The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptideZhirong Wang, Ting Zhang, Xuemei Xu
Human Vaccines & Immunotherapeutics|May 30, 2025
Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experienceKrishna Mohan Vadrevu, Siddharth Reddy Chiteti, Raju Dugyala, et al.
Human Vaccines & Immunotherapeutics|May 27, 2025
An investigation of HPV vaccination willingness and influential factors among college students in Beijing based on the BeSD framework and evaluation of momentary intervention effectXuan Li, Jiarui Zheng, Ziyan Zhang, et al.
Human Vaccines & Immunotherapeutics|May 23, 2025
T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccineKirk Haltaufderhyde, Andres H Gutiérrez, Mitchell McAllister, et al.
Pageof 650